+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vascular Imaging - Global Strategic Business Report

  • PDF Icon

    Report

  • 258 Pages
  • June 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 5141497
The global market for Vascular Imaging was estimated at US$6.2 Billion in 2025 and is projected to reach US$7.7 Billion by 2032, growing at a CAGR of 3.2% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Vascular Imaging Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Vascular Imaging Technologies?

Vascular imaging technologies have become indispensable in the diagnosis and management of vascular diseases, offering detailed visualizations of blood vessels and circulatory systems. The increasing prevalence of cardiovascular and peripheral vascular diseases has led to a surge in the demand for advanced imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA). These technologies provide critical insights into vascular conditions, enabling early diagnosis, precise treatment planning, and effective monitoring of disease progression. As healthcare providers strive to improve patient outcomes and reduce the burden of vascular diseases, the adoption of vascular imaging technologies is expected to grow, driving market expansion.

How Are Technological Advancements Enhancing Vascular Imaging?

Technological advancements have significantly enhanced the capabilities of vascular imaging, making it more accurate, non-invasive, and accessible. The development of high-resolution imaging systems and contrast agents has improved the clarity and detail of vascular images, allowing for better detection of abnormalities and blockages. The integration of artificial intelligence (AI) and machine learning algorithms into imaging systems has further revolutionized the field, enabling automated image analysis and predictive diagnostics. Additionally, innovations in portable and point-of-care imaging devices have made vascular imaging more accessible, particularly in remote or underserved regions. These technological advancements are driving the widespread adoption of vascular imaging technologies, as they offer greater precision and convenience in the diagnosis and management of vascular diseases.

What Are the Emerging Trends in Vascular Imaging?

The vascular imaging market is witnessing several emerging trends that are shaping its growth and development. One notable trend is the increasing use of hybrid imaging techniques, such as PET/CT and PET/MRI, which combine the strengths of different imaging modalities to provide more comprehensive and accurate assessments of vascular conditions. Another trend is the growing emphasis on non-invasive imaging methods, driven by the need to reduce patient discomfort and the risk of complications associated with invasive procedures. The rise in demand for personalized medicine is also influencing the market, as imaging technologies are increasingly being used to tailor treatment plans based on individual patient profiles. Furthermore, the expanding use of AI-driven imaging analytics is enabling more precise and faster interpretation of vascular images, improving diagnostic accuracy and efficiency.

What Factors Are Driving the Growth of the Vascular Imaging Market?

The growth in the vascular imaging market is driven by several factors, including the rising prevalence of vascular diseases such as atherosclerosis, aneurysms, and deep vein thrombosis. The increasing demand for early and accurate diagnosis, fueled by the growing awareness of the importance of preventive healthcare, is also a significant driver. Additionally, the continuous advancements in imaging technologies, including the development of more sophisticated and non-invasive imaging systems, are expanding the range of diagnostic options available to healthcare providers. The shift towards value-based care, which emphasizes the importance of accurate diagnostics in improving patient outcomes and reducing healthcare costs, is further boosting the adoption of vascular imaging technologies. Moreover, the growing focus on research and development in the field of vascular imaging, supported by government initiatives and funding, is contributing to the market`s growth.

Report Scope

The report analyzes the Vascular Imaging market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Modality (CT Modality, MRI Modality, Ultrasound Modality, Nuclear Medicine Modality); End-Use (Hospitals End-Use, Imaging Centers End-Use, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the CT Modality segment, which is expected to reach US$2.8 Billion by 2032 with a CAGR of a 4.2%. The MRI Modality segment is also set to grow at 3.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $1.9 Billion in 2025, and China, forecasted to grow at an impressive 6.4% CAGR to reach $1.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Vascular Imaging Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Imaging Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Vascular Imaging Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Carestream Health, Inc., Esaote SpA, Fujifilm Corporation, GE Healthcare and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Vascular Imaging market report include:

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 12,825 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Vascular Imaging - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-invasive Imaging Techniques
  • Technological Advancements in Vascular Ultrasound
  • Growth of MRI and CT Angiography in Vascular Diagnostics
  • Adoption of AI and Machine Learning in Vascular Imaging Analysis
  • Increasing Use of Portable and Handheld Imaging Devices
  • Expanding Applications of Vascular Imaging in Disease Screening
  • Innovations in Contrast Media and Imaging Agents
  • Integration of Imaging with Vascular Interventional Procedures
  • Growing Awareness and Early Diagnosis of Vascular Conditions
  • Cost-effectiveness and Accessibility of New Imaging Modalities
  • Rising Prevalence of Cardiovascular Diseases Globally
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Vascular Imaging Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for CT Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for CT Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for CT Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for MRI Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Ultrasound Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Nuclear Medicine Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Nuclear Medicine Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Nuclear Medicine Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 29: USA Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 30: USA Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: USA 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 35: Canada Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 36: Canada Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: Canada 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
JAPAN
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 41: Japan Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 42: Japan Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: Japan 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CHINA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 47: China Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 48: China Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: China 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
EUROPE
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 56: Europe Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 57: Europe Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 58: Europe 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
FRANCE
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 59: France Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 62: France Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 63: France Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 64: France 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
GERMANY
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 68: Germany Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 69: Germany Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 70: Germany 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 74: Italy Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 75: Italy Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 76: Italy 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 80: UK Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 81: UK Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 82: UK 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
SPAIN
  • Table 83: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 84: Spain Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 85: Spain 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 86: Spain Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 87: Spain Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 88: Spain 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
RUSSIA
  • Table 89: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 90: Russia Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 91: Russia 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 92: Russia Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 93: Russia Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 94: Russia 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of Europe Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of Europe 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 99: Rest of Europe Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 100: Rest of Europe 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
AUSTRALIA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

Table Information